Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days 1.22€ 1.22€ Friday, 22nd Dec 2023 PHGN.F stock ended at 1.22€. During the day the stock fluctuated 0% from a day low at 1.22€ to a day high of 1.22€.
90 days 1.20€ 1.22€
52 weeks 0.92€ 1.48€

Historical Pharming Group N.V. prices

Date Open High Low Close Volume
Mar 14, 2023 1.09€ 1.09€ 1.09€ 1.09€ 0
Mar 13, 2023 1.05€ 1.06€ 1.05€ 1.06€ 0
Mar 10, 2023 1.11€ 1.12€ 1.11€ 1.12€ 0
Mar 09, 2023 1.15€ 1.15€ 1.14€ 1.14€ 0
Mar 08, 2023 1.15€ 1.15€ 1.15€ 1.15€ 0
Mar 07, 2023 1.14€ 1.14€ 1.14€ 1.14€ 0
Mar 06, 2023 1.15€ 1.15€ 1.14€ 1.14€ 0
Mar 03, 2023 1.15€ 1.15€ 1.15€ 1.15€ 0
Mar 02, 2023 1.14€ 1.15€ 1.11€ 1.15€ 5 580
Mar 01, 2023 1.14€ 1.14€ 1.14€ 1.14€ 0
Feb 28, 2023 1.14€ 1.14€ 1.14€ 1.14€ 0
Feb 27, 2023 1.09€ 1.13€ 1.09€ 1.13€ 0
Feb 24, 2023 1.07€ 1.10€ 1.07€ 1.10€ 0
Feb 23, 2023 1.07€ 1.08€ 1.07€ 1.08€ 0
Feb 22, 2023 1.06€ 1.06€ 1.05€ 1.05€ 0
Feb 21, 2023 1.08€ 1.08€ 1.06€ 1.06€ 0
Feb 20, 2023 1.06€ 1.06€ 1.06€ 1.06€ 0
Feb 17, 2023 1.08€ 1.08€ 1.08€ 1.08€ 0
Feb 16, 2023 1.19€ 1.19€ 1.14€ 1.14€ 0
Feb 15, 2023 1.21€ 1.21€ 1.20€ 1.20€ 0
Feb 14, 2023 1.22€ 1.22€ 1.22€ 1.22€ 0
Feb 13, 2023 1.20€ 1.22€ 1.20€ 1.22€ 0
Feb 10, 2023 1.21€ 1.21€ 1.21€ 1.21€ 0
Feb 09, 2023 1.22€ 1.23€ 1.22€ 1.23€ 0
Feb 08, 2023 1.24€ 1.24€ 1.23€ 1.23€ 0
Click to get the best stock tips daily for free!

About Pharming Group N.V.

Pharming Group N.V. Pharming Group N.V., a biopharmaceutical company, develops and commercialize protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally. The company's lead product is Ruconest, a recombinant human C1 esterase inhibitor that is used for the treatment of acute hereditary angioedema. It also engages in the development of rhC1INH for the treatment ... PHGN.F Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT